Navigation Links
Ching-Hon Pui, M.D., recognized with American Association for Cancer Research award
Date:3/25/2011

(MEMPHIS, Tenn. March 25, 2011) Ching-Hon Pui, M.D., a world renowned leukemia physician and researcher at St. Jude Children's Research Hospital, is the recipient of the 2011 Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Research from the American Association for Cancer Research (AACR).

The AACR Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Research is presented to a scientist who has made exceptional achievements in clinical cancer research. Pui will accept the award during the 102nd AACR Annual Meeting, in Orlando, Fla., in early April.

Pui is chair of the Department of Oncology at St. Jude and an American Cancer Society Professor. Additionally, he is co-leader of the hospital's Hematological Malignancies Program; medical director of the St. Jude International Outreach China Program; and holder of the Fahad Nassar Al-Rashid Chair of Leukemia Research.

"One of Dr. Pui's great strengths, beyond his unsurpassed wealth of knowledge about treating leukemia, is that he brings together a broad array of scientists and clinical investigators to participate in developing and conducting new ALL treatment protocols," said Dr. William E. Evans, St. Jude director and CEO, and a long-time collaborator of Dr. Pui's. "He is like a great conductor drawing together the best musicians to create something that is extraordinary and far greater than any one person playing alone."

Pui has played a key role in a series of treatment protocols responsible for raising cure rates of acute lymphoblastic leukemia (ALL), the most common childhood cancer, from about 70 percent in the early 1980s to an unprecedented 90 percent at St. Jude today. His work has shown that cranial irradiation, once regarded as a standard treatment for childhood ALL, can be omitted altogether, thus sparing patients from devastating side effects and enhancing their quality of life.

More recently, his treatment approach resulted in a remarkably high cure rate approaching 90 percent in older adolescents with ALL. Pui's team pioneered the use of pharmacodynamics and pharmacogenetics to individualize chemotherapy and to optimize the use of existing drugs; and used genome-wide analyses to accurately classify leukemias, to identify cooperative genetic mutations of leukemic cells and molecular targets for therapy, and to disclose host genes associated with the development of leukemia.

Pui has authored more than 700 original articles and chapters, edited seven books and monographs, and serves as section editor or editorial board member for several esteemed journals. He is also one of the most highly cited authors in clinical medicine research. Pui's many awards and honors include elected memberships in the Association of American Physicians and the American Society for Clinical Investigation, election as a fellow of the American Association for the Advancement of Science, the 2009 AACR Team Science Award, and the 2010 Castle Connolly National Physician of the Year Award.


'/>"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-595-3061
St. Jude Children's Research Hospital
Source:Eurekalert  

Related medicine news :

1. Pier Paolo Pandolfi, M.D., Ph.D., to receive Pezcoller-AACR International Award for Cancer Research
2. Donald M. Lloyd-Jones, M.D., recipient of the American Heart Associations 2010 Chairmans Award
3. Douglas A. Jabs, M.D., honored with Jackson Memorial Lecture by the American Academy of Ophthalmology
4. O. Marion Burton, M.D., F.A.A.P., addresses American Academy of Pediatrics in new term as president
5. Anthony S. Fauci, M.D., on results from the CAPRISA 004 microbicide study
6. Renowned Psychiatrist, Lyubov Y Gorelik, M.D., is selected to represent New York in The Leading Physicians of the World
7. Gino Tutera, M.D., F.A.C.O.G. Brings SottoPelle Therapy to Middle Tennessee, Opens Practice in Nashville Medical District
8. Joan Miller, M.D., receives 2010 Leadership Award for the Advancement of Women Faculty
9. University of Utah afib specialist, Marcos Daccarett, M.D., wins Young Investigator Award
10. Nationally Known Interventional Neuroradiologist John Pile-Spellman, M.D., Joins Neurological Surgery, P.C.
11. AMA Honors Vice Admiral John Mateczun, M.D., With Top Government Service Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ching-Hon Pui, M.D., recognized with American Association for Cancer Research award
(Date:5/31/2016)... ... 31, 2016 , ... Twenty years ago it was revolutionary: enabling the people ... the voices they hear. But this approach has proven transformative, both for people who ... gained credibility and now is used around the world, but it still lags in ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... ... commercial molecular diagnostics device that enables unprecedented portability and convenience. , The Cube ... four inches cubed in size, the Cube fits easily into any space, whether ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... WaterField Designs, ... digital-minded professionals, announces the waxed-canvas and leather Duo Dopp Kit , the ideal ... canvas or ballistic nylon, the Duo is smartly designed for Dad’s grooming ...
(Date:5/31/2016)... ... May 31, 2016 , ... Phynd Technologies, Inc. announced recently the signing of ... TX and Shore Medical Center – Somers Point, NJ. The new clients range in ... demonstrating the breadth of Phynd’s solution and its interoperability. , Houston Methodist is a ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... firm and statement solutions provider, for the tenth consecutive year as a ... issue of Advertising Age, and SourceLink ranked eighteenth in the “U.S. CRM/Direct Marketing ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... Mich. , May 31, 2016  Diplomat Pharmacy, Inc. ... pharmacy, has announced that Phil Hagerman , Chairman & ... the upcoming William Blair 36 th Annual Growth Stock ... Mr. Hagerman and Mr. Whelan are scheduled to present at ... Central Time. A live audio-only webcast of the presentation and ...
(Date:5/31/2016)... , May 31, 2016 Mundipharma ... initiation of a first-in-human clinical trial of its investigational ... - S101 is currently being developed for the treatment ... is designed to evaluate the safety and tolerability of ... several sites across the United States ...
(Date:5/31/2016)... The global biomaterials market is driven by the ... from chronic diseases. According to research report, "Global Biomaterials Market ... Forecasts (2016-2021) - (By Value; By Material Type - Polymer, ... By Region-North America, Europe , APAC, ROW; ... Italy , Japan , ...
Breaking Medicine Technology: